Kinase inhibitor TQB3912
Term · Oncology and biomedicine · MLC-T-ONC-014644
An orally bioavailable small molecule protein kinase inhibitor, with potential antineoplastic activity. Upon oral administration, kinase inhibitor TQB3912 may target, bind to and inhibit the activity of a protein kinase that plays an important role in tumor cell survival, proliferation, migration, and differentiation.
| Identifier | MLC-T-ONC-014644 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | protein kinase inhibitor TQB3912 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014644",
"term": "Kinase inhibitor TQB3912",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable small molecule protein kinase inhibitor, with potential antineoplastic activity. Upon oral administration, kinase inhibitor TQB3912 may target, bind to and inhibit the activity of a protein kinase that plays an important role in tumor cell survival, proliferation, migration, and differentiation.",
"synonyms": [
"protein kinase inhibitor TQB3912"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/kinase-inhibitor-tqb3912/"
}
Record 9,781 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.